Terlipressin acetate

Min.Order / FOB Price:Get Latest Price

1 Gram	Negotiable

1 Gram

Negotiable

Min.Order :1 Gram
Purity: 99% purity
Payment Terms : T/T,Other

Keywords

[N-α-Triglycyl-8-lysine]-vasopressin 14636-12-5 99% purity

Quick Details

Appearance:White solid
Application:API
PackAge:According to the need to packing
ProductionCapacity:100|Kilogram|Month
Storage:sealed,dry,low temperature
Transportation:air,sea and courier

Superiority:

Terlipressin acetate Basic information

Product Name:   Terlipressin acetate
Synonyms:   [N-α-Triglycyl-8-lysine]-vasopressin;130: PN: WO2010033207 SEQID: 171 claiMed protein;1-Triglycyl-8-lysine Vasopressin;Nα-Glycyl-glycyl-glycyl-[8-lysine]-vasopressin;Nα-Glycyl-glycyl-glycyl-lysine-vasopressin;Nα-Glycylglycylglycyl-vasopressin;Nα-Gly-Gly-Gly-8-Lys-vasopressin;Terlipressin, Terlipressine, Terlipressina, Terlipressinum
CAS:   14636-12-5
MF:   C52H74N16O15S2
MW:   1227.37
EINECS:   238-680-8
Product Categories:
Mol File:   14636-12-5.mol

Details:

Terlipressin acetate Chemical Properties
Melting point    >170°C (dec.)
Boiling point    1824.0±65.0 °C(Predicted)
density    1.46±0.1 g/cm3(Predicted)
storage temp.    Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility    DMSO (Slightly), Methanol (Slightly)
pka   9.90±0.15(Predicted)
form    Solid
color    White
CAS DataBase Reference   14636-12-5(CAS DataBase Reference)

Chemical Properties   N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is White Solid
Uses   N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is used norepinephrine-resistant septic shock and hepatorenal syndrome. N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin is also used in the treatment of acute variceal bleeding.
Clinical Use   Treatment of bleeding oesophageal varices
Drug interactions   Potentially hazardous interactions with other drugs
None known
Metabolism   Terlipressin is metabolised by tissue peptidases resulting in the slow release of lypressin. Terlipressin is almost completely metabolised in the kidneys and liver, with less than 1% of terlipressin and less than 0.1% of lypressin excreted in the urine.

View All